Leading Pharmaceutical Company sanofi-aventis Chooses Cegedim Dendrite as Global Partner

PARIS--(Marketwire - June 03, 2009) - Cegedim Dendrite (PINKSHEETS: CGMJF), global leader in Customer Relationship Management for the life sciences industry, announces a 3 year agreement with leading pharmaceutical company sanofi-aventis to provide Mobile Intelligence CRM solution to over 20 000 users across 28 countries including USA, France and Japan.

Cegedim Dendrite's proven expertise in the Pharmaceutical industry, the flexibility of its Mobile Intelligence solution and its unique capabilities to support users across Primary Care, Stakeholders Management and Pharmacy Management at a global level, have been key drivers of sanofi-aventis' choice.

"We have demonstrated the best capability to proactively support sanofi-aventis' business model evolution towards multichannel CRM, Key Account and KOL management, with the lowest investment," explained Laurent Labrune, Chief Executive Officer of Cegedim Dendrite.

The integration of Mobile Intelligence solution with OneKey, the most robust healthcare database, will enable sanofi-aventis to benefit from a unique database on a worldwide scale, gaining the company an optimized R.O.I. on data management.

The solution has just been deployed for the Managed Markets group in the U.S. France and Spain will follow in the first Quarter of 2010.

About Cegedim Dendrite:

Cegedim Dendrite is the life sciences industry's leading provider of CRM solutions. Pharmaceutical by design, the company's innovative business solutions and global reach incorporate a thorough understanding of local, regional and worldwide trends. Cegedim Dendrite enables more than 200,000 users in many of the world's top companies stay ahead of market challenges. Cegedim Dendrite also provides sales, marketing and regulatory compliance solutions in more than 80 countries. www.cegedimdendrite.com.

About Cegedim:

Founded in 1969, Cegedim is a global technology and services company specializing in the healthcare field. Cegedim supplies services, technological tools, specialized software, data flow management services and databases. Its offerings are targeted notably at healthcare industries, pharmaceutical companies, healthcare professionals and insurance companies. Cegedim employs 8,200 people in more than 80 countries and generated revenue of EUR 849 million in 2008. Cegedim is listed in Paris (EURONEXT: CGM). www.cegedim.com.

About sanofi-aventis:

Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone. Sanofi-aventis is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

Media Inquiries: Cegedim Dendrite Karine Renaud +33 (0)1 49 09 23 74 karine.renaud@cegedimdendrite.com

Cegedim Group Aude Balleydier +33 (0)1 49 09 68 81 aude.balleydier@cegedim.fr

This announcement was originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.

SOURCE: CEGEDIM

Related terms: business, ceo, crm, france, healthcare, insurance, investment, japan, knowledge management, local, market, marketing, media, new york, nyse, paris, pharmaceuticals, pharmacy, revenue, sales, software, spain, technology